| JUPITER ASIA PACIFIC INCOME FUND (IRL) C USD CAP | RVI ASIA EX-JAPÓN | 41,85% | 87,32% | 69,94% | 122,73% |
| DWS CONCEPT NISSAY JAPAN VALUE EQUITY USD TFCH | RVI JAPÓN VALOR | 41,84% | · | · | · |
| INVESCO NASDAQ BIOTECH UCITS ETF ACC | RVI BIOTECNOLOGÍA | 41,84% | 69,51% | 49,31% | 147,98% |
| L&G MULTI-STRATEGY ENHANCED COMMODITIES UCITS ETF USD ACC ETF | RVI MATERIAS PRIMAS | 41,84% | 39,11% | · | · |
| FIDELITY FUNDS-LATIN AMERICA E-ACC-EUR | RVI LATINOAMÉRICA | 41,82% | 57,75% | 61,80% | 60,41% |
| FIDELITY FUNDS-TECHNOLOGY OPPORTUNITIES Y-ACC-USD | RVI TECNOLOGÍA | 41,82% | 87,36% | 60,51% | · |
| MAN JAPAN COREALPHA EQUITY IXX H GBP NET-DIS A | RVI JAPÓN | 41,82% | 109,76% | 212,77% | · |
| ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF USD (ACC) | RVI BIOTECNOLOGÍA | 41,78% | 69,44% | 49,19% | · |
| SANTANDER GO EMERGING MARKETS EQUITY AE CAP | RVI EMERGENTES | 41,77% | 91,72% | · | · |
| WELLINGTON EMERGING MARKETS EQUITY FUND USD D ACC | RVI EMERGENTES | 41,77% | 96,67% | 62,00% | 148,77% |
